The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains neutral rating on hannover re with target price of 267 euros
UBS has maintained a "Neutral" rating on Hannover Re shares with a target price of 267 euros, following a strong premium growth of 7.6% despite lower-than-expected price effects. The shares were down 1.4% at EUR 254.60, indicating a potential upside of 4.87%. The Q4 2024 results are set to be released on March 13, 2025.
ubs maintains neutral rating for hannover re with target price of 267 euros
UBS has maintained a "Neutral" rating for Hannover Re, setting a target price of 267 euros following the company's recent figures and January renewals. Analyst Will Hardcastle noted an unexpected premium growth of 7.6%, although the price effect fell short of expectations. Key figures for 2024 aligned with consensus estimates.
ubs maintains neutral rating for hannover re with target price of 267 euro
UBS AG has maintained a "Neutral" rating for Hannover Re shares, setting a target price of EUR 267 following a review of recent figures and January renewals. Analyst Will Hardcastle noted a surprising premium growth of 7.6%, despite a less favorable price effect than anticipated. Currently, Hannover Re shares are trading at EUR 254.60, reflecting a potential growth of 4.87% towards the target price.
UBS maintains neutral rating for Hannover Re with target price of 267 euros
UBS has maintained a "Neutral" rating for Hannover Re, setting a target price of 267 euros following the company's recent figures and January renewals. Analyst Will Hardcastle noted an unexpected premium growth of 7.6 percent, although the price effect fell short of expectations. Key figures for 2024 aligned closely with consensus estimates.
ubs maintains neutral rating for hannover re with target price of 267 euros
UBS has maintained a "Neutral" rating for Hannover Re, setting a target price of 267 euros after positive premium growth of 7.6% was reported, despite lower-than-expected price effects. The stock was trading at EUR 254.60, reflecting a 5.5% increase since early 2025, with a potential upside of 4.87%. The Q4 2024 balance sheet is anticipated on March 13, 2025.
ubs maintains buy rating for swiss re with target price of 150 francs
UBS has maintained a 'Buy' rating for Swiss Re, setting a target price of 150 francs. Analyst Will Hardcastle noted that concerns over negative price trends in January renewals and the impact of California wildfires could affect future estimates and first-quarter catastrophe budgets. Swiss Re remains a favored choice in the industry.
ubs maintains neutral rating on munich re amid market challenges
UBS has maintained a "Neutral" rating for Munich Re, setting a target price of 555 euros. Analyst Will Hardcastle noted that negative price trends in January renewals and severe wildfires in California could impact future consensus estimates and deplete first-quarter catastrophe budgets. Swiss Re remains the analyst's preferred choice in the industry.
ubs upgrades swiss re to buy with target price of 150 francs
UBS has maintained its 'Buy' rating for Swiss Re, setting a price target of 150 francs. Analyst Will Hardcastle noted that concerns over negative price trends in January renewals and the impact of California wildfires could affect future estimates, but Swiss Re remains a favored choice in the industry.
ubs maintains sell rating for generali with target price of 23.70 euros
UBS has maintained its "Sell" rating for Generali, setting a target price of 23.70 euros. Analyst Will Hardcastle noted that the recent asset management deal with Natixis offers economies of scale and a wider range of services.
UBS downgrades Munich Re to neutral raises price target to 555 euros
UBS has raised its price target for Munich Re shares from 540 to 555 euros but downgraded the rating from "Buy" to "Neutral." Analyst Will Hardcastle cited appropriate valuation and price risks in the upcoming renewals, noting that the higher profit target for 2025 is unlikely to lead to increased shareholder distributions.